Great Point Partners LLC Intercept Pharmaceuticals, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$9.17 - $19.29 $5.51 Million - $11.6 Million
601,322 New
601,322 $6.65 Million
Q4 2022

Feb 14, 2023
BUY
$11.61 - $16.11 $4.92 Million - $6.83 Million
423,850 Added 403.67%
528,850 $6.54 Million
Q3 2022

Nov 14, 2022
BUY
$12.21 - $19.7 $1.28 Million - $2.07 Million
105,000 New
105,000 $1.47 Million

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email